The EGFR gene was amplified in 19 out of 34 MB tumors (55.88%), 7 from 15 small cell GBM cases (46.67%) and 4 cases of 8 PNET samples (50%) assessed by FISH (Figure 3A). The gene discussed is EGFR; the disease is primitive neuroectodermal tumor.